These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 30855701)

  • 1. Positron emission tomography neuroimaging in neurodegenerative diseases: Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis.
    Barc K; Kuźma-Kozakiewicz M
    Neurol Neurochir Pol; 2019; 53(2):99-112. PubMed ID: 30855701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroimaging biomarkers of neurodegenerative diseases and dementia.
    Risacher SL; Saykin AJ
    Semin Neurol; 2013 Sep; 33(4):386-416. PubMed ID: 24234359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Image analyser-assisted morphometry of the locus coeruleus in Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis.
    Hoogendijk WJ; Pool CW; Troost D; van Zwieten E; Swaab DF
    Brain; 1995 Feb; 118 ( Pt 1)():131-43. PubMed ID: 7894999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic Biomarkers and Neurodegeneration: A Pathway Enrichment Analysis of Alzheimer's Disease, Parkinson's Disease, and Amyotrophic Lateral Sclerosis.
    Kori M; Aydın B; Unal S; Arga KY; Kazan D
    OMICS; 2016 Nov; 20(11):645-661. PubMed ID: 27828769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unraveling Molecular and Genetic Insights into Neurodegenerative Diseases: Advances in Understanding Alzheimer's, Parkinson's, and Huntington's Diseases and Amyotrophic Lateral Sclerosis.
    Ciurea AV; Mohan AG; Covache-Busuioc RA; Costin HP; Glavan LA; Corlatescu AD; Saceleanu VM
    Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sex and gender differences in Alzheimer's disease, Parkinson's disease, and Amyotrophic Lateral Sclerosis: A narrative review.
    Nicoletti A; Baschi R; Cicero CE; Iacono S; Re VL; Luca A; Schirò G; Monastero R;
    Mech Ageing Dev; 2023 Jun; 212():111821. PubMed ID: 37127082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis caused by neurotoxins?
    Vandervort WJ
    Del Med J; 1987 Aug; 59(8):533-4, 537. PubMed ID: 3666247
    [No Abstract]   [Full Text] [Related]  

  • 8. The relationship between four GWAS-identified loci in Alzheimer's disease and the risk of Parkinson's disease, amyotrophic lateral sclerosis, and multiple system atrophy.
    Chen Y; Cao B; Chen X; Ou R; Wei Q; Zhao B; Wu Y; Yuan L; Shang HF
    Neurosci Lett; 2018 Nov; 686():205-210. PubMed ID: 30144538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New opportunities for treatment and prevention of neurodegenerative diseases with PTP1B inhibitors.
    Kołodziej D; Sobczak Ł; Łączkowski KZ
    Future Med Chem; 2023 Aug; 15(16):1443-1447. PubMed ID: 37610866
    [No Abstract]   [Full Text] [Related]  

  • 10. Evaluation of treatment effects in Alzheimer's and other neurodegenerative diseases by MRI and MRS.
    Mueller SG; Schuff N; Weiner MW
    NMR Biomed; 2006 Oct; 19(6):655-68. PubMed ID: 16986115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The genetic overlap between Alzheimer's disease, amyotrophic lateral sclerosis, Lewy body dementia, and Parkinson's disease.
    Wightman DP; Savage JE; Tissink E; Romero C; Jansen IE; Posthuma D
    Neurobiol Aging; 2023 Jul; 127():99-112. PubMed ID: 37045620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Copper homeostasis and neurodegenerative disorders (Alzheimer's, prion, and Parkinson's diseases and amyotrophic lateral sclerosis).
    Gaggelli E; Kozlowski H; Valensin D; Valensin G
    Chem Rev; 2006 Jun; 106(6):1995-2044. PubMed ID: 16771441
    [No Abstract]   [Full Text] [Related]  

  • 13. Dessert or Poison? The Roles of Glycosylation in Alzheimer's, Parkinson's, Huntington's Disease, and Amyotrophic Lateral Sclerosis.
    Yang J; Li H; Zhao Y
    Chembiochem; 2023 Aug; 24(16):e202300017. PubMed ID: 37440197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Occupational Exposures and Neurodegenerative Diseases-A Systematic Literature Review and Meta-Analyses.
    Gunnarsson LG; Bodin L
    Int J Environ Res Public Health; 2019 Jan; 16(3):. PubMed ID: 30691095
    [No Abstract]   [Full Text] [Related]  

  • 15. The Big Bluff of Amyotrophic Lateral Sclerosis Diagnosis: The Role of Neurodegenerative Disease Mimics.
    Bicchi I; Emiliani C; Vescovi A; Martino S
    Neurodegener Dis; 2015; 15(6):313-21. PubMed ID: 26227992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Future Directions in Imaging Neurodegeneration.
    Masdeu JC
    Curr Neurol Neurosci Rep; 2017 Jan; 17(1):9. PubMed ID: 28210978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomarkers in Neurodegenerative Diseases.
    Jeromin A; Bowser R
    Adv Neurobiol; 2017; 15():491-528. PubMed ID: 28674995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurodegenerative Disorders of Alzheimer, Parkinsonism, Amyotrophic Lateral Sclerosis and Multiple Sclerosis: An Early Diagnostic Approach for Precision Treatment.
    Pathak N; Vimal SK; Tandon I; Agrawal L; Hongyi C; Bhattacharyya S
    Metab Brain Dis; 2022 Jan; 37(1):67-104. PubMed ID: 34719771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomarkers in Parkinson's disease (recent update).
    Sharma S; Moon CS; Khogali A; Haidous A; Chabenne A; Ojo C; Jelebinkov M; Kurdi Y; Ebadi M
    Neurochem Int; 2013 Sep; 63(3):201-29. PubMed ID: 23791710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proinflammatory IL-17 levels in serum/cerebrospinal fluid of patients with neurodegenerative diseases: a meta-analysis study.
    Gautam AS; Pulivarthi CB; Singh RK
    Naunyn Schmiedebergs Arch Pharmacol; 2023 Mar; 396(3):577-588. PubMed ID: 36504126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.